Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 8Lymphoid 7Myeloid 3Sarcoma 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myelodysplastic Syndromes 5Lymphoma 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 4Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Hodgkin Disease 3Blast Crisis 3Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Hematologic Neoplasms 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Thrombocythemia, Essential 1Recurrence 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Philadelphia Chromosome 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Cyclophosphamide 53fludarabine phosphate 52Peripheral Blood Stem Cell Transplantation 52Busulfan 39Tacrolimus 36Mycophenolic Acid 32Methotrexate 31Cyclosporine 31Antilymphocyte Serum 31Filgrastim 26Whole-Body Irradiation 25Cytarabine 24Radiotherapy 21Methylprednisolone 20Cord Blood Stem Cell Transplantation 18Melphalan 17Imatinib Mesylate 17Etoposide 16Flow Cytometry 12Thiotepa 11fludarabine 10Dasatinib 10Therapeutics 9Sirolimus 9Granulocyte Colony-Stimulating Factor 9nilotinib 8sargramostim 7Psychiatric Rehabilitation 7Decitabine 7Prednisone 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Blast Crisis × Vincristine × Myeloid × Clear all
NCT00002766 2016-02-22

Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
170 enrolled 7 charts
LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Lymphoma, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01670084 2015-10-30

Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Mayo Clinic

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00763763 2011-10-05

AFR07

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed
55 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Philadelphia Chromosome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡